Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain

Stig Lyngbæk; Charlotte Andersson; Jacob L Marott; Daniél V Møller; Michael Christiansen; Kasper K Iversen; Peter Clemmensen; Jesper Eugen-Olsen; Peter R Hansen; Jørgen L Jeppesen

doi:10.1373/clinchem.2013.203778

Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain

Stig Lyngbæk, Charlotte Andersson, Jacob L Marott, Daniél V Møller, Michael Christiansen, Kasper K Iversen, Peter Clemmensen, Jesper Eugen-Olsen, Peter R Hansen, Jørgen L Jeppesen

48 Citations (Scopus)

Abstract

Plasma concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict mortality in several clinical settings, but the long-term prognostic importance of suPAR in chest pain patients admitted on suspicion of non-ST-segment elevation acute coronary syndrome (NSTEACS) is uncertain.

Original language	English
Journal	Clinical Chemistry (Washington, DC)
Volume	59
Issue number	11
Pages (from-to)	1621-1629
Number of pages	9
ISSN	0009-9147
DOIs	https://doi.org/10.1373/clinchem.2013.203778
Publication status	Published - Nov 2013

Access to Document

10.1373/clinchem.2013.203778

Cite this

Lyngbæk, S., Andersson, C., Marott, J. L., Møller, D. V., Christiansen, M., Iversen, K. K., Clemmensen, P., Eugen-Olsen, J., Hansen, P. R., & Jeppesen, J. L. (2013). Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain. Clinical Chemistry (Washington, DC), 59(11), 1621-1629. https://doi.org/10.1373/clinchem.2013.203778

Lyngbæk, S , Andersson, C , Marott, JL , Møller, DV, Christiansen, M, Iversen, KK, Clemmensen, P, Eugen-Olsen, J , Hansen, PR & Jeppesen, JL 2013, 'Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain', Clinical Chemistry (Washington, DC), vol. 59, no. 11, pp. 1621-1629. https://doi.org/10.1373/clinchem.2013.203778

@article{33ae0a37263143cab48d62b51a34634c,

title = "Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain",

abstract = "Plasma concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict mortality in several clinical settings, but the long-term prognostic importance of suPAR in chest pain patients admitted on suspicion of non-ST-segment elevation acute coronary syndrome (NSTEACS) is uncertain.",

author = "Stig Lyngb{\ae}k and Charlotte Andersson and Marott, {Jacob L} and M{\o}ller, {Dani{\'e}l V} and Michael Christiansen and Iversen, {Kasper K} and Peter Clemmensen and Jesper Eugen-Olsen and Hansen, {Peter R} and Jeppesen, {J{\o}rgen L}",

year = "2013",

month = nov,

doi = "10.1373/clinchem.2013.203778",

language = "English",

volume = "59",

pages = "1621--1629",

journal = "Clinical Chemistry (Washington, DC)",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry, Inc",

number = "11",

}

TY - JOUR

T1 - Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain

AU - Lyngbæk, Stig

AU - Andersson, Charlotte

AU - Marott, Jacob L

AU - Møller, Daniél V

AU - Christiansen, Michael

AU - Iversen, Kasper K

AU - Clemmensen, Peter

AU - Eugen-Olsen, Jesper

AU - Hansen, Peter R

AU - Jeppesen, Jørgen L

PY - 2013/11

Y1 - 2013/11

N2 - Plasma concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict mortality in several clinical settings, but the long-term prognostic importance of suPAR in chest pain patients admitted on suspicion of non-ST-segment elevation acute coronary syndrome (NSTEACS) is uncertain.

AB - Plasma concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict mortality in several clinical settings, but the long-term prognostic importance of suPAR in chest pain patients admitted on suspicion of non-ST-segment elevation acute coronary syndrome (NSTEACS) is uncertain.

U2 - 10.1373/clinchem.2013.203778

DO - 10.1373/clinchem.2013.203778

M3 - Journal article

C2 - 23842203

SN - 0009-9147

VL - 59

SP - 1621

EP - 1629

JO - Clinical Chemistry (Washington, DC)

JF - Clinical Chemistry (Washington, DC)

IS - 11

ER -

Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain

Abstract

Access to Document

Fingerprint

Cite this